515 related articles for article (PubMed ID: 28583328)
1. 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems.
Beck RCR; Chaves PS; Goyanes A; Vukosavljevic B; Buanz A; Windbergs M; Basit AW; Gaisford S
Int J Pharm; 2017 Aug; 528(1-2):268-279. PubMed ID: 28583328
[TBL] [Abstract][Full Text] [Related]
2. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.
Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S
J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134
[TBL] [Abstract][Full Text] [Related]
3. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
4. Redispersible 3D printed nanomedicines: An original application of the semisolid extrusion technique.
de Oliveira TV; de Oliveira RS; Dos Santos J; Funk NL; Petzhold CL; Beck RCR
Int J Pharm; 2022 Aug; 624():122029. PubMed ID: 35853566
[TBL] [Abstract][Full Text] [Related]
5. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants.
Kempin W; Franz C; Koster LC; Schneider F; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2017 Jun; 115():84-93. PubMed ID: 28232106
[TBL] [Abstract][Full Text] [Related]
6. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
[TBL] [Abstract][Full Text] [Related]
7. Poly(ɛ-caprolactone) and Eudragit E blends modulate the drug release profiles from FDM printlets.
Dos Santos J; Kielholz T; Funk NL; Balbinot GS; Daitx TDS; Petzhold CL; Buchner S; Collares FM; Windbergs M; Beck RCR
Int J Pharm; 2023 Nov; 647():123533. PubMed ID: 37863446
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
9. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
10. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
11. Tablets containing drug-loaded polymeric nanocapsules: an innovative platform.
Friedrich RB; Bastos MO; Fontana MC; Ourique AF; Beck RC
J Nanosci Nanotechnol; 2010 Sep; 10(9):5885-8. PubMed ID: 21133121
[TBL] [Abstract][Full Text] [Related]
12. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
Dos Santos J; Deon M; da Silva GS; Beck RCR
Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
[TBL] [Abstract][Full Text] [Related]
13. Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug Delivery.
Long J; Gholizadeh H; Lu J; Bunt C; Seyfoddin A
Curr Pharm Des; 2017; 23(3):433-439. PubMed ID: 27784251
[TBL] [Abstract][Full Text] [Related]
14. 3D printing of drug-loaded gyroid lattices using selective laser sintering.
Fina F; Goyanes A; Madla CM; Awad A; Trenfield SJ; Kuek JM; Patel P; Gaisford S; Basit AW
Int J Pharm; 2018 Aug; 547(1-2):44-52. PubMed ID: 29787894
[TBL] [Abstract][Full Text] [Related]
15. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
16. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
17. Direct Granule Feeding of Thermal Droplet Deposition 3D Printing of Porous Pharmaceutical Solid Dosage Forms Free of Plasticisers.
McDonagh T; Belton P; Qi S
Pharm Res; 2022 Mar; 39(3):599-610. PubMed ID: 35194719
[TBL] [Abstract][Full Text] [Related]
18. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
19. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
Funk NL; Fantaus S; Beck RCR
Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
[TBL] [Abstract][Full Text] [Related]
20. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
